Literature DB >> 11040437

Variation of the mexT gene, a regulator of the MexEF-oprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa.

H Maseda1, K Saito, A Nakajima, T Nakae.   

Abstract

We found three variations of wild-type strains in terms of mexT-mediated regulation of the MexEF-OprN efflux pump, in which overexpression of the pump results in nfxC-type antibiotic resistance in Pseudomonas aeruginosa. Type-I: the mexT gene of the wild-type strain encoded inactive MexT and the nfxC-type mutants derived from this parent had an additional mutation in mexT converting MexT from the inactive to the active form. Type-II: The mexT gene in the wild-type strain had an 8-bp insert producing inactive MexT and the nfxC-type mutants from this parent had a deletion of the 8-bp insert converting inactive MexT to the active form. Type-III: Both the wild-type strain and its nfxC-type derivative produced identical and active MexT. The nfxC mutant from this parent must have an additional mutation. The original nfxC mutant isolated in 1990 might be derived from the Type-I parent strain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040437     DOI: 10.1111/j.1574-6968.2000.tb09367.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  67 in total

1.  mexEF-oprN multidrug efflux operon of Pseudomonas aeruginosa: regulation by the MexT activator in response to nitrosative stress and chloramphenicol.

Authors:  Hossam Fetar; Christie Gilmour; Rachael Klinoski; Denis M Daigle; Charles R Dean; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  MexT regulates the type III secretion system through MexS and PtrC in Pseudomonas aeruginosa.

Authors:  Yongxin Jin; Hongjiang Yang; Mingqiang Qiao; Shouguang Jin
Journal:  J Bacteriol       Date:  2010-11-12       Impact factor: 3.490

3.  Amino Acid Substitutions Account for Most MexS Alterations in Clinical nfxC Mutants of Pseudomonas aeruginosa.

Authors:  Charlotte Richardot; Paulo Juarez; Katy Jeannot; Isabelle Patry; Patrick Plésiat; Catherine Llanes
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

4.  Characterization of a resistance-nodulation-cell division transporter system associated with the syr-syp genomic island of Pseudomonas syringae pv. syringae.

Authors:  Hyojeung Kang; Dennis C Gross
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

5.  Substrate-dependent utilization of OprM or OpmH by the Pseudomonas aeruginosa MexJK efflux pump.

Authors:  Rungtip Chuanchuen; Takeshi Murata; Naomasa Gotoh; Herbert P Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

6.  Development of a novel biofilm continuous culture method for simultaneous assessment of architecture and gaseous metabolite production.

Authors:  Yutaka Yawata; Nobuhiko Nomura; Hiroo Uchiyama
Journal:  Appl Environ Microbiol       Date:  2008-07-07       Impact factor: 4.792

Review 7.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 8.  Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.

Authors:  Lucía Fernández; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics.

Authors:  Hansi Kumari; Deepak Balasubramanian; Diansy Zincke; Kalai Mathee
Journal:  J Med Microbiol       Date:  2014-01-25       Impact factor: 2.472

10.  Nosocomial acquisition of Pseudomonas aeruginosa resistant to both ciprofloxacin and imipenem: a risk factor and laboratory analysis.

Authors:  M R Mueller; M K Hayden; S K Fridkin; D K Warren; L Phillips; K Lolans; J P Quinn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-26       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.